Last reviewed · How we verify
NCT05106621: BLOC-OP
AN INTELLIGENT MODEL FOR THE OPERATIVE BLOCK
trial in Artificial Intelligence in Operating Room in 142 participants. Status unknown.
30 November 2022
Quick facts
| Lead sponsor | University of Parma |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 142 |
| Start date | 1 November 2021 |
| Primary completion | 30 November 2022 |
| Estimated completion | 30 November 2022 |
| Sites | 1 location across Italy |
Conditions studied
- Artificial Intelligence in Operating Room — all drugs for Artificial Intelligence in Operating Room →
Sponsor
University of Parma
Who can join
18 and older, any sex, with Artificial Intelligence in Operating Room. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Perioperative medicine is characterized by a very delicate path; it is composed, in fact, of a series of highly specialized clinical measures managed by various professionals (surgeons, anesthetists, intensivists, nurses, etc.), who work together to ensure the best quality of all phases of the path (preoperative , intra and postoperative). On the other hand, it is necessary to underline the huge resources needed to provide surgical services. Organizational optimization, based on specific analyzes, could lead to a more careful management of resources in this area, avoiding waste due to early closure of the operating room or unexpected extension of the same. In recent years, precisely to respond to the need to analyze large quantities of information, the use of artificial intelligence techniques, and in particular of machine learning, is becoming increasingly popular, a branch of artificial intelligence that aims, through the use of algorithms and statistical model, to infer new knowledge in a way automatic. Such technologies appear to possess excellent analytical skills both in the clinical and, above all, organizational fields. The data that are emerging in the literature on this issue, although still the first in this regard, seem to confirm this hypothesis.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Artificial intelligence and anesthesia: a narrative review.
Bellini V, Rafano Carnà E, Russo M, Di Vincenzo F, et al · · 2022 · cited 36× · PMID 35928743 · DOI 10.21037/atm-21-7031 -
Internet of Things and New Technologies for Tracking Perioperative Patients With an Innovative Model for Operating Room Scheduling: Protocol for a Development and Feasibility Study.
Bottani E, Bellini V, Mordonini M, Pellegrino M, et al · · 2023 · cited 1× · PMID 37405821 · DOI 10.2196/45477
Verify or expand the search:
- PubMed search for NCT05106621
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Parma trials
Trials by the same sponsor.
- NCT07242079 — Effect Of Pulmonary Rehabilitation in Patients With Alpha-1 Antitrypsin Deficiency · completed
- NCT06977802 — Design and Implementation of a Mobile App for Promoting Healthy and Sustainable Eating Among Students at the University · NA · completed
- NCT06347094 — Precision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)Phenols · NA · recruiting
- NCT06028659 — Investigation of in Vivo Endogenous and/or Exogenous Production of Phenolic Metabolites Using (un)Targeted Metabolomics · NA · recruiting
- NCT06455956 — Use of miRNAs in Growth Hormone Deficiency (GHD) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05106621 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Parma
- Last refreshed: 17 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05106621.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing